The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 02, 2018

Filed:

Apr. 18, 2016
Applicant:

David Gordon Bermudes, Woodland Hills, CA (US);

Inventor:

David Gordon Bermudes, Woodland Hills, CA (US);

Assignee:

Aviex Technologies LLC, New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/04 (2006.01); C12N 15/74 (2006.01); A61K 39/145 (2006.01); C12N 1/36 (2006.01); C12N 9/24 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/74 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); C12N 1/36 (2013.01); C12N 9/2402 (2013.01); C12Y 302/01018 (2013.01); A61K 2039/522 (2013.01); A61K 2039/523 (2013.01); A61K 2039/542 (2013.01); A61K 2039/552 (2013.01); C12N 2760/16134 (2013.01);
Abstract

A live bacterium, having a DNA construct stabilized against transduction of other bacteria, having a promoter sequence and encoding a fusion peptide, comprising a bacterial secretion peptide portion and a non-bacterial immunogenic polypeptide portion, having a nucleotide sequence coding for the non-bacterial immunogenic polypeptide portion which has at least one codon optimized for bacterial expression. The bacterium has a secretion mechanism which interacts with at least the bacterial secretion peptide portion to cause a secretion of the fusion peptide from the bacterium, and a genetic virulence attenuating mutation. The bacterium is adapted to act as an animal vaccine, to transiently infect a tissue of the animal, and cause an immunity response to the non-bacterial immunogenic polypeptide portion in the animal to a non-bacterial organism associated with the non-bacterial immunogenic polypeptide portion.


Find Patent Forward Citations

Loading…